Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry

The effectiveness and safety of venous thromboembolism (VTE) treatment with apixaban, demonstrated in phase III trials, need to be confirmed in daily care. Using data from the prospective, noninterventional cross-indication Dresden NOAC Registry we evaluated rates of VTE recurrence and bleeding comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyer-Westendorf, Jan, Marten, Sandra, Tittl, Luise, Naue, Christiane, Bornhäuser, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096533/
https://www.ncbi.nlm.nih.gov/pubmed/33969261
http://dx.doi.org/10.1055/s-0041-1728675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096533/
https://www.ncbi.nlm.nih.gov/pubmed/33969261
http://dx.doi.org/10.1055/s-0041-1728675

Ejemplares similares